Tolebrutinib, RITUXIMAB clinical trials

A Randomized Open Label Trial Exploring the Soluble and Imaging Biomarker Dynamic Responses to Tolebrutinib Compared to Rituximab Treatment in Patients with Multiple Sclerosis (MS)

This study compares two treatments, Tolebrutinib and Rituximab, for Multiple Sclerosis (MS). Researchers are looking at how these medicines affect certain markers in the body, especially in the fluid around the brain and spine, to see which one works best at protecting nerves.